Karine Johnston, LICSW CCA
Locations
Showing 18 Locations-
-
Mclean Hospital
MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer • A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
-
Eleos • Center for the Neuroscience of Psychedelics • Adelia Therapeutics • Vicente Sederberg • Brigham and Women's Hospital • Boston University • Harvard Medical School • Boston Children's Hospital • Invicro • Massachusetts General Hospital • Beth Israel Deaconess Medical Center • Beth Israel Medical Center • Massachusetts Eye and Ear Infirmary • Tufts Medical Center • Concert Pharmaceuticals • Psy Therapeutics • Hyka Therapeutics • Mobile Ketamine Boston • InhaleMD • Enveric Biosciences
MAZAKALI • Psilos Group
Bob Peatman • Stephen Krupa • Joseph Tucker • Doug Drysdale • Adam Von Reyn • Rachael Junard • Jordan Tishler
Program Manager - Center for Neuroscience of Psychedelics • Director Quality Assurance Regulatory Affairs • Director Clinical Operations • Director, Clinical Operations • Formulation/Analytical Chemist • Director, Quality Assurance • Senior Analytical Chemist • Associate Director, Analytical Chemistry • Director, Neurochemistry • Director, Program Manager • Principal Scientist, Medicinal Chemistry
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • EEG Studies of Ketamine General Anesthesia • Ketamine for Depression: An MRI Study • Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Ketamine Infusion for Treatment-resistant Major Depressive Disorder • Immunomodulatory Properties of Ketamine in Sepsis • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Prevention of Post Mastectomy With Intraoperative Ketamine • The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures • Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder • Effect of Ketamine on Opioid-Induced Hyperalgesia • Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients • Ketamine for Major Depressive Disorder • The Impact of Ketamine on the Reward Circuitry of Suicidal Patients • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy • Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder • Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients • N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression • EEG Studies of Sevoflurane-Induced General Anesthesia • Avoiding Neuromuscular Blockers to Reduce Complications • Prevention of Phantom Limb Pain After Transtibial Amputation • The PATHFINDER Study: A Feasibility Trial • EEG Monitoring in the Emergency Department • Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor • The Effect of Sodium Oxybate on Sleep Architecture • Evaluation of the Efficacy of Sodium Oxybate (Xyrem) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia • A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
-
Hypnalgesics, LLC
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
-
Diamond Therapeutics • Takeda • Xenomics • Cohen Veterans Bioscience • Genzyme, a Sanofi Company • Sage Therapeutics • Javelin Pharmaceuticals • Biogen • Millennium Pharmaceuticals, Inc. • The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School • Cambridge Biotherapies
General Catalyst
Glenn Short
Research Fellow for the Project on Psychedelics Law and Regulation (POPLAR)
Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine • Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
-
Lennham Pharmaceuticals
-
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
-
Dr. Shaun Logan
-
Tepha, Inc.
-
Marlborough, Massachusetts, USA
Boston Scientific Corporation
-
Eva Bartos • Julia Costa • Coastal Coaching Sheryl Melanson • Nora Verzone • Rebecca J. Briggs, RYT, CN • Cassie Cerasuolo • Maryann D'Amato Wood • Jomaris Perez • Andrea Rodgers • Peggy Kelly • Cristina Brennan • Stacy Young • Lisa Magoulas • Erika DeJesus • Mary Xatse • Melissa Davis • Leah Somers • Gerald Speller • Janelle Casella • Allison Nichols • Kat Ogar • Danielle N Shea Tan • Laura Denis • Daniel James • Brenda Lima • Jenn Pinard • Alethea Copelas • Julianne McLaughlin • Angeline Cowgill • Shannon Lagasse • Jen Barrows • Elizabeth Fulks
-
Tufts University
-
Ketamine Greater Boston
-
Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
-
North Dartmouth, Massachusetts, USA
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
-
Springfield, Massachusetts, USA
Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia
-
Veritas Mind Health
-
University of Massachusetts, Worcester
Memantine Augmentation of Antidepressants • Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia